Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

08 Jan 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated January 08, 2016 titled ‘Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel bi-specific monoclonal antibody targeting CD38’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..